A Patient Navigator may assist during your patient's treatment with coverage, reimbursement and financial assistance support.
If eligible commercially insured patients need assistance with their drug and/or drug administration out-of-pocket costs, the OCREVUS Co-pay Program may help.
To get started, call (844) OCREVUS/(844) 627-3887 or visit OCREVUSCopay.com/HCP.
Eligibility criteria and benefit limits apply. Not valid for patients using federal or state government programs to pay for their medicine and/or administration of their Genentech medicine. Patients must be taking the Genentech medicine for an FDA-approved indication. Please visit the Co-pay Program website for the full list of Terms and Conditions.
For eligible patients with commercial or public health insurance, your OCREVUS Patient Navigator offers referrals to independent co-pay assistance foundations that may be able to help.
Independent co-pay assistance foundations have their own rules for eligibility. Genentech has no involvement or influence in independent foundation decision-making or eligibility criteria and does not know if a foundation will be able to help your patient. We can only refer your patient to a foundation that supports their disease state. This information is provided as a resource for you. Genentech does not endorse or show preference for any particular foundation. The foundations in this list may not be the only ones that might be able to help your patient.
If patients don’t have health insurance coverage or have financial concerns and meet eligibility criteria, they may be able to get Genentech medicine at no cost from the Genentech Patient Foundation.
Call (888) 941-3331 to speak with a live Foundation Specialist. We offer support in many different languages.
To be eligible for free Genentech medicine from the Genentech Patient Foundation, insured patients who have coverage for their medicine should try to pursue other forms of financial assistance, if available, and meet certain income requirements. Uninsured patients and insured patients without coverage for their medicine must meet a different set of income requirements. Genentech reserves the right to modify or discontinue the program at any time and to verify the accuracy of information submitted.
This coding information may assist you as you complete the payer forms for OCREVUS and OCREVUS ZUNOVO. These resources are provided for informational purposes only. Please visit CMS.gov or other payers’ websites to obtain additional guidance on their processes related to billing and coding for single-use vials and wastage.
Correct coding is the responsibility of the provider submitting the claim for the item or service. Please check with the payer to verify codes and special billing requirements. Genentech does not make any representation or guarantee concerning reimbursement or coverage for any item or service.
Complete and submit a form electronically.
If your patient’s health insurance plan has issued a denial, your Field Reimbursement Manager (FRM) or OCREVUS Patient Navigator can provide resources as you prepare an appeal submission, as per your patient’s plan requirements.
If a plan issues a denial:
The denial should be reviewed, along with the health insurance plan’s guidelines, to determine what to include in your patient’s appeal submission
Your FRM or OCREVUS Patient Navigator has local payer coverage expertise and can help you determine specific requirements for your patient
A sample appeal letter and additional considerations are available in Resources.
Appeals cannot be completed or submitted by OCREVUS Access Solutions on your behalf.
OCREVUS Access Solutions can conduct a benefits investigation (BI) to help you determine if OCREVUS and OCREVUS ZUNOVO are covered, if prior authorizations (PAs) are required, which specialty pharmacy (SP) the health insurance plan prefers and if financial assistance might be needed.
Potential outcomes of a BI:
Once the BI is complete, your OCREVUS Patient Navigator will walk your patient through his or her insurance coverage for OCREVUS or OCREVUS ZUNOVO. A BI may be initiated once the OCREVUS Start Form is submitted to OCREVUS Access Solutions.
Forms can be downloaded from Enrollment or submitted online via My Patient Solutions®.
A sample appeal letter and additional considerations are available in Resources.
The completion and submission of coverage- or reimbursement-related documentation are the responsibility of the patient and health care provider. Genentech makes no representation or guarantee concerning coverage or reimbursement for any service or item.
Your OCREVUS Patient Navigator can help you identify if a prior authorization (PA) is necessary and offer resources as you request it for your patient. Once your practice has submitted a PA, your Patient Navigator can follow up with the payer regarding the PA status. Remember, submitting the PA is the responsibility of the practice. Both the Start Form and the Patient Consent Form must be received before OCREVUS Access Solutions can begin helping your patient.
Forms can be downloaded from Enrollment or submitted online via My Patient Solutions®.
If your patient’s request for a PA is not granted, your Clinical and Reimbursement Manager (CRM) or OCREVUS Patient Navigator can work with you to determine your next steps. You can find more tips like this in Resources.
The completion and submission of coverage- or reimbursement-related documentation are the responsibility of the patient and health care provider. Genentech makes no representation or guarantee concerning coverage or reimbursement for any service or item.
While awaiting a health insurance coverage determination, eligible patients may receive free medicine through the OCREVUS ZUNOVO Starter Program. The OCREVUS ZUNOVO Starter Program is available for eligible insured people who have been prescribed OCREVUS ZUNOVO and are experiencing a delay in insurance approval of >5 business days.
If you believe your patient qualifies for the OCREVUS ZUNOVO Starter Program, submit the completed OCREVUS Start Form, including the completed Patient Consent Form on page 4 and Starter section on page 6, to OCREVUS Access Solutions.
Forms can be downloaded from Enrollment or submitted online via My Patient Solutions®.
For more information, please contact your OCREVUS representative.
Subject to eligibility requirements and terms and conditions. This program is void where prohibited by law and may not be used in or by residents of restricted states, if applicable.
Your OCREVUS Patient Navigator can help you prepare for subsequent OCREVUS or OCREVUS ZUNOVO treatments by automatically reverifying your patient’s benefits prior to the next scheduled treatment.
To enroll in Genentech patient support services, both you and your patient will need to complete the required forms.
Enroll patients online and manage service requests using My Patient Solutions®
Both forms must be received before Genentech can begin helping your patient. Only the information requested on these forms is required. Providing unrequested documents or information will delay processing.
OCREVUS Access Solutions works with specialty pharmacies (SPs) to help patients receive their medicine.
An SP may provide the following services:
You can work with your preferred SP or contact OCREVUS Access Solutions to learn which SP the patient’s health insurance plan requires.
Genentech does not influence or advocate the use of any one specialty distributor or SP. We make no representation or guarantee of service or coverage of any item.
With buy and bill, the practice purchases the medication in advance, then bills the patient’s health insurance plan for reimbursement. The practice is responsible for storing and handling the drug, as well as collecting the patient’s co-pay for both the drug and its administration. With buy and bill, practices can maintain a stock of the drug, giving them the flexibility to treat patients when clinically appropriate.
Genentech has contracted with a network of authorized specialty distributors to service practices choosing to purchase OCREVUS and OCREVUS ZUNOVO through the buy and bill model. Customers can purchase OCREVUS and OCREVUS ZUNOVO through authorized specialty distributors and wholesalers that have made a commitment to product integrity. These partners have agreed to distribute only products purchased directly from Genentech and not to distribute OCREVUS and OCREVUS ZUNOVO through secondary channels.
Distributor | Telephone | Fax | Web Orders |
---|---|---|---|
ASD Healthcare (Cencora) | 800-746-6273 | 800-547-9413 | www.asdhealthcare.com |
Besse Medical (Cencora) | 800-543-2111 | 800-543-8695 | www.besse.com/home |
Cardinal Health Specialty Distribution | 866-677-4844 | N/A | www.cardinalhealth.com/en/solutions/specialty-distribution.html |
Dakota Drug | 866-210-5887 | 763-421-0661 | www.dakdrug.com/ContactUs.aspx |
DMS Pharmaceutical | 877-788-1100 | 847-518-1105 | www.dmspharma.com/contact-us |
McKesson Plasma and Biologics (MPB) | 877-625-2566 | N/A | www.mckesson.com/Pharmaceutical-Distribution/Plasma-Biologics/ |
Oncology Supply (Cencora) | 800-633-7555 | 800-248-8205 | www.oncologysupply.com/ |
Distributor | Telephone | Fax | Web Orders |
---|---|---|---|
ASD Healthcare (Cencora) | 800-746-6273 | 800-547-9413 | www.asdhealthcare.com |
Besse Medical (Cencora) | 800-543-2111 | 800-543-8695 | www.besse.com/home |
Cardinal Health Specialty Distribution | 866-677-4844 | N/A | www.cardinalhealth.com/en/solutions/specialty-distribution.html |
CuraScript SD (Priority Health) | 877-599-7748 | 800-862-6208 | curascriptsd.com/Contact-Us |
McKesson Plasma and Biologics (MPB) | 877-625-2566 | N/A | www.mckesson.com/Pharmaceutical-Distribution/Plasma-Biologics/ |
Morris & Dickson | 800-388-3833 | 318-524-3096 | www.morrisdickson.com/products/specialty/ |
Oncology Supply (Cencora) | 800-633-7555 | 800-248-8205 | www.oncologysupply.com/ |
Distributor | Telephone | Fax | Web Orders |
---|---|---|---|
ASD Healthcare (Cencora) | 800-746-6273 | 800-547-9413 | www.asdhealthcare.com |
Besse Medical (Cencora) | 800-543-2111 | 800-543-8695 | www.besse.com/home |
Cardinal Health Specialty Distribution | 866-677-4844 | N/A | www.cardinalhealth.com/en/solutions/specialty-distribution.html |
CuraScript SD (Priority Health) | 877-599-7748 | 800-862-6208 | curascriptsd.com/Contact-Us |
McKesson Specialty Health (McKesson Specialty Care Distribution Corporation) | 800-482-6700 | N/A | www.mckesson.com/specialty/ |
Morris & Dickson | 800-388-3833 | 318-524-3096 | www.morrisdickson.com/products/specialty/ |
Oncology Supply (Cencora) | 800-633-7555 | 800-248-8205 | www.oncologysupply.com/ |
Distributor | Telephone | Fax | Web Orders |
---|---|---|---|
ASD Healthcare (Cencora) | 800-746-6273 | 800-547-9413 | www.asdhealthcare.com |
Besse Medical (Cencora) | 800-543-2111 | 800-543-8695 | www.besse.com/home |
Cardinal Health Specialty Distribution | 866-677-4844 | N/A | www.cardinalhealth.com/en/solutions/specialty-distribution.html |
CuraScript SD (Priority Health) | 877-599-7748 | 800-862-6208 | curascriptsd.com/Contact-Us |
McKesson Specialty Health (McKesson Specialty Care Distribution Corporation) | 800-482-6700 | N/A | www.mckesson.com/specialty/ |
Metro Medical (Cardinal Health) | 800-768-2002 | 615-256-4194 | www.metromedicalorder.com |
Morris & Dickson | 800-388-3833 | 318-524-3096 | www.morrisdickson.com/products/specialty/ |
Oncology Supply (Cencora) | 800-633-7555 | 800-248-8205 | www.oncologysupply.com/ |
Distributor | Telephone | Fax | Web Orders |
---|---|---|---|
Cardinal Health Puerto Rico | 787-625-4200 | N/A | cardinalhealth.pr/ |
Cesar Castillo (Puerto Rico) | 787-999-1616 | 787-999-1618 | cesarcastillo.com/ |
Many specialty pharmacies are in-network with access to this product. If you are a pharmacy and would like to request product access, please visit our Indirect Access Program website.
We work with these authorized distributors and specialty pharmacies to provide OCREVUS and OCREVUS ZUNOVO to patients and the prescribers.
Genentech does not influence or advocate the use of any one specialty distributor or specialty pharmacy. We make no representation or guarantee of service or coverage of any item.
To learn more about the Genentech Spoilage Replacement Program, click here.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.